nodes	percent_of_prediction	percent_of_DWPC	metapath
Nisoldipine—CYP1A2—Imiquimod—skin cancer	0.12	0.166	CbGbCtD
Nisoldipine—ABCB1—Vismodegib—skin cancer	0.0728	0.101	CbGbCtD
Nisoldipine—CYP1A2—Vemurafenib—skin cancer	0.0658	0.0909	CbGbCtD
Nisoldipine—CYP3A4—Imiquimod—skin cancer	0.0629	0.0869	CbGbCtD
Nisoldipine—CYP3A4—Temozolomide—skin cancer	0.0629	0.0869	CbGbCtD
Nisoldipine—CYP1A2—Dacarbazine—skin cancer	0.0504	0.0697	CbGbCtD
Nisoldipine—CYP3A4—Vismodegib—skin cancer	0.0436	0.0603	CbGbCtD
Nisoldipine—CYP3A7—Docetaxel—skin cancer	0.0404	0.0559	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0404	0.0559	CbGbCtD
Nisoldipine—ABCB1—Dactinomycin—skin cancer	0.0382	0.0528	CbGbCtD
Nisoldipine—CYP3A4—Vemurafenib—skin cancer	0.0345	0.0476	CbGbCtD
Nisoldipine—CYP3A5—Docetaxel—skin cancer	0.0303	0.0419	CbGbCtD
Nisoldipine—CYP1A2—Fluorouracil—skin cancer	0.0296	0.0409	CbGbCtD
Nisoldipine—CACNA1S—pes—skin cancer	0.0278	0.586	CbGeAlD
Nisoldipine—ABCB1—Docetaxel—skin cancer	0.0197	0.0273	CbGbCtD
Nisoldipine—CYP3A4—Docetaxel—skin cancer	0.0118	0.0163	CbGbCtD
Nisoldipine—CACNA1D—ear—skin cancer	0.00642	0.135	CbGeAlD
Nisoldipine—CACNA1C—connective tissue—skin cancer	0.0015	0.0317	CbGeAlD
Nisoldipine—CACNB2—head—skin cancer	0.0011	0.0231	CbGeAlD
Nisoldipine—CYP1A2—nipple—skin cancer	0.00108	0.0228	CbGeAlD
Nisoldipine—CACNA1C—female reproductive system—skin cancer	0.00106	0.0223	CbGeAlD
Nisoldipine—CACNA2D1—head—skin cancer	0.00103	0.0217	CbGeAlD
Nisoldipine—CACNA1D—head—skin cancer	0.000959	0.0202	CbGeAlD
Nisoldipine—CACNA1C—head—skin cancer	0.000886	0.0187	CbGeAlD
Nisoldipine—CACNB2—lymph node—skin cancer	0.000769	0.0162	CbGeAlD
Nisoldipine—ABCB1—blood vessel—skin cancer	0.000766	0.0161	CbGeAlD
Nisoldipine—CACNA2D1—lymph node—skin cancer	0.000722	0.0152	CbGeAlD
Nisoldipine—CACNA1D—lymph node—skin cancer	0.000672	0.0142	CbGeAlD
Nisoldipine—Syncope—Imiquimod—skin cancer	0.00067	0.00293	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Bleomycin—skin cancer	0.00067	0.00293	CcSEcCtD
Nisoldipine—Hypotension—Vemurafenib—skin cancer	0.000668	0.00292	CcSEcCtD
Nisoldipine—Myocardial infarction—Bleomycin—skin cancer	0.000666	0.00291	CcSEcCtD
Nisoldipine—Stomatitis—Bleomycin—skin cancer	0.000662	0.00289	CcSEcCtD
Nisoldipine—Palpitations—Imiquimod—skin cancer	0.000661	0.00289	CcSEcCtD
Nisoldipine—Loss of consciousness—Imiquimod—skin cancer	0.000657	0.00287	CcSEcCtD
Nisoldipine—Muscular weakness—Temozolomide—skin cancer	0.000656	0.00287	CcSEcCtD
Nisoldipine—Colitis—Docetaxel—skin cancer	0.000654	0.00286	CcSEcCtD
Nisoldipine—Cough—Imiquimod—skin cancer	0.000652	0.00285	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000652	0.00285	CcSEcCtD
Nisoldipine—Haematuria—Bleomycin—skin cancer	0.000648	0.00283	CcSEcCtD
Nisoldipine—Ataxia—Fluorouracil—skin cancer	0.000644	0.00282	CcSEcCtD
Nisoldipine—Dysphagia—Temozolomide—skin cancer	0.000643	0.00281	CcSEcCtD
Nisoldipine—Arthralgia—Imiquimod—skin cancer	0.000636	0.00278	CcSEcCtD
Nisoldipine—Chest pain—Imiquimod—skin cancer	0.000636	0.00278	CcSEcCtD
Nisoldipine—Myalgia—Imiquimod—skin cancer	0.000636	0.00278	CcSEcCtD
Nisoldipine—Anxiety—Imiquimod—skin cancer	0.000634	0.00277	CcSEcCtD
Nisoldipine—Discomfort—Imiquimod—skin cancer	0.000629	0.00275	CcSEcCtD
Nisoldipine—Dry skin—Fluorouracil—skin cancer	0.000628	0.00274	CcSEcCtD
Nisoldipine—Dry mouth—Imiquimod—skin cancer	0.000622	0.00272	CcSEcCtD
Nisoldipine—Decreased appetite—Vemurafenib—skin cancer	0.000622	0.00272	CcSEcCtD
Nisoldipine—CACNA1C—lymph node—skin cancer	0.00062	0.0131	CbGeAlD
Nisoldipine—Stomatitis—Dactinomycin—skin cancer	0.000618	0.0027	CcSEcCtD
Nisoldipine—Oedema—Imiquimod—skin cancer	0.00061	0.00267	CcSEcCtD
Nisoldipine—Hypoaesthesia—Bleomycin—skin cancer	0.000607	0.00265	CcSEcCtD
Nisoldipine—Muscular weakness—Fluorouracil—skin cancer	0.000604	0.00264	CcSEcCtD
Nisoldipine—Dysuria—Temozolomide—skin cancer	0.000601	0.00263	CcSEcCtD
Nisoldipine—Shock—Imiquimod—skin cancer	0.0006	0.00262	CcSEcCtD
Nisoldipine—Tachycardia—Imiquimod—skin cancer	0.000595	0.0026	CcSEcCtD
Nisoldipine—Pollakiuria—Temozolomide—skin cancer	0.000594	0.00259	CcSEcCtD
Nisoldipine—Dysphagia—Fluorouracil—skin cancer	0.000592	0.00259	CcSEcCtD
Nisoldipine—Erectile dysfunction—Temozolomide—skin cancer	0.000592	0.00259	CcSEcCtD
Nisoldipine—Hyperhidrosis—Imiquimod—skin cancer	0.00059	0.00258	CcSEcCtD
Nisoldipine—Weight increased—Temozolomide—skin cancer	0.000585	0.00256	CcSEcCtD
Nisoldipine—Weight decreased—Temozolomide—skin cancer	0.000582	0.00254	CcSEcCtD
Nisoldipine—Anorexia—Imiquimod—skin cancer	0.000582	0.00254	CcSEcCtD
Nisoldipine—Body temperature increased—Vemurafenib—skin cancer	0.000565	0.00247	CcSEcCtD
Nisoldipine—Pharyngitis—Dactinomycin—skin cancer	0.000565	0.00247	CcSEcCtD
Nisoldipine—Stomatitis—Temozolomide—skin cancer	0.000559	0.00244	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000556	0.00243	CcSEcCtD
Nisoldipine—Insomnia—Imiquimod—skin cancer	0.000552	0.00241	CcSEcCtD
Nisoldipine—Paraesthesia—Imiquimod—skin cancer	0.000548	0.00239	CcSEcCtD
Nisoldipine—Chills—Bleomycin—skin cancer	0.000547	0.00239	CcSEcCtD
Nisoldipine—Cardiac failure congestive—Docetaxel—skin cancer	0.000545	0.00238	CcSEcCtD
Nisoldipine—Dyspnoea—Imiquimod—skin cancer	0.000544	0.00238	CcSEcCtD
Nisoldipine—Somnolence—Imiquimod—skin cancer	0.000542	0.00237	CcSEcCtD
Nisoldipine—Alopecia—Bleomycin—skin cancer	0.000539	0.00235	CcSEcCtD
Nisoldipine—Sinusitis—Temozolomide—skin cancer	0.000538	0.00235	CcSEcCtD
Nisoldipine—Dyspepsia—Imiquimod—skin cancer	0.000537	0.00235	CcSEcCtD
Nisoldipine—Decreased appetite—Imiquimod—skin cancer	0.00053	0.00232	CcSEcCtD
Nisoldipine—Hypersensitivity—Vemurafenib—skin cancer	0.000527	0.0023	CcSEcCtD
Nisoldipine—Atrial fibrillation—Docetaxel—skin cancer	0.000522	0.00228	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Fluorouracil—skin cancer	0.000521	0.00227	CcSEcCtD
Nisoldipine—Myocardial infarction—Fluorouracil—skin cancer	0.000518	0.00226	CcSEcCtD
Nisoldipine—Stomatitis—Fluorouracil—skin cancer	0.000515	0.00225	CcSEcCtD
Nisoldipine—Conjunctivitis—Fluorouracil—skin cancer	0.000513	0.00224	CcSEcCtD
Nisoldipine—Hypoaesthesia—Temozolomide—skin cancer	0.000512	0.00224	CcSEcCtD
Nisoldipine—Pharyngitis—Temozolomide—skin cancer	0.000511	0.00223	CcSEcCtD
Nisoldipine—Chills—Dactinomycin—skin cancer	0.00051	0.00223	CcSEcCtD
Nisoldipine—Oedema peripheral—Temozolomide—skin cancer	0.000507	0.00221	CcSEcCtD
Nisoldipine—Pruritus—Vemurafenib—skin cancer	0.000506	0.00221	CcSEcCtD
Nisoldipine—Alopecia—Dactinomycin—skin cancer	0.000503	0.0022	CcSEcCtD
Nisoldipine—Feeling abnormal—Imiquimod—skin cancer	0.000503	0.0022	CcSEcCtD
Nisoldipine—Epistaxis—Fluorouracil—skin cancer	0.000498	0.00218	CcSEcCtD
Nisoldipine—Visual impairment—Temozolomide—skin cancer	0.000496	0.00217	CcSEcCtD
Nisoldipine—Sinusitis—Fluorouracil—skin cancer	0.000496	0.00216	CcSEcCtD
Nisoldipine—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000495	0.00216	CcSEcCtD
Nisoldipine—Ill-defined disorder—Bleomycin—skin cancer	0.000493	0.00215	CcSEcCtD
Nisoldipine—Anaemia—Bleomycin—skin cancer	0.000491	0.00214	CcSEcCtD
Nisoldipine—Diarrhoea—Vemurafenib—skin cancer	0.000489	0.00214	CcSEcCtD
Nisoldipine—Migraine—Docetaxel—skin cancer	0.000487	0.00213	CcSEcCtD
Nisoldipine—Urticaria—Imiquimod—skin cancer	0.000485	0.00212	CcSEcCtD
Nisoldipine—Body temperature increased—Imiquimod—skin cancer	0.000482	0.00211	CcSEcCtD
Nisoldipine—Tinnitus—Temozolomide—skin cancer	0.00048	0.0021	CcSEcCtD
Nisoldipine—Malaise—Bleomycin—skin cancer	0.000479	0.00209	CcSEcCtD
Nisoldipine—Leukopenia—Bleomycin—skin cancer	0.000475	0.00208	CcSEcCtD
Nisoldipine—Rhinitis—Fluorouracil—skin cancer	0.000475	0.00208	CcSEcCtD
Nisoldipine—Dizziness—Vemurafenib—skin cancer	0.000473	0.00207	CcSEcCtD
Nisoldipine—Hypoaesthesia—Fluorouracil—skin cancer	0.000472	0.00206	CcSEcCtD
Nisoldipine—Pharyngitis—Fluorouracil—skin cancer	0.000471	0.00206	CcSEcCtD
Nisoldipine—Ataxia—Docetaxel—skin cancer	0.000465	0.00203	CcSEcCtD
Nisoldipine—Cough—Bleomycin—skin cancer	0.000463	0.00202	CcSEcCtD
Nisoldipine—Chills—Temozolomide—skin cancer	0.000462	0.00202	CcSEcCtD
Nisoldipine—Ill-defined disorder—Dactinomycin—skin cancer	0.00046	0.00201	CcSEcCtD
Nisoldipine—Anaemia—Dactinomycin—skin cancer	0.000458	0.002	CcSEcCtD
Nisoldipine—Liver function test abnormal—Docetaxel—skin cancer	0.000457	0.002	CcSEcCtD
Nisoldipine—Alopecia—Temozolomide—skin cancer	0.000455	0.00199	CcSEcCtD
Nisoldipine—Dry skin—Docetaxel—skin cancer	0.000453	0.00198	CcSEcCtD
Nisoldipine—Chest pain—Bleomycin—skin cancer	0.000452	0.00198	CcSEcCtD
Nisoldipine—Myalgia—Bleomycin—skin cancer	0.000452	0.00198	CcSEcCtD
Nisoldipine—Orthostatic hypotension—Docetaxel—skin cancer	0.000452	0.00197	CcSEcCtD
Nisoldipine—Rash—Vemurafenib—skin cancer	0.000451	0.00197	CcSEcCtD
Nisoldipine—Dermatitis—Vemurafenib—skin cancer	0.000451	0.00197	CcSEcCtD
Nisoldipine—Hypersensitivity—Imiquimod—skin cancer	0.000449	0.00196	CcSEcCtD
Nisoldipine—Headache—Vemurafenib—skin cancer	0.000448	0.00196	CcSEcCtD
Nisoldipine—Discomfort—Bleomycin—skin cancer	0.000447	0.00195	CcSEcCtD
Nisoldipine—Malaise—Dactinomycin—skin cancer	0.000447	0.00195	CcSEcCtD
Nisoldipine—Leukopenia—Dactinomycin—skin cancer	0.000443	0.00194	CcSEcCtD
Nisoldipine—Dysgeusia—Temozolomide—skin cancer	0.000439	0.00192	CcSEcCtD
Nisoldipine—Confusional state—Bleomycin—skin cancer	0.000437	0.00191	CcSEcCtD
Nisoldipine—Oedema—Bleomycin—skin cancer	0.000433	0.00189	CcSEcCtD
Nisoldipine—Pruritus—Imiquimod—skin cancer	0.000432	0.00189	CcSEcCtD
Nisoldipine—Dysphagia—Docetaxel—skin cancer	0.000428	0.00187	CcSEcCtD
Nisoldipine—Nausea—Vemurafenib—skin cancer	0.000425	0.00186	CcSEcCtD
Nisoldipine—Myalgia—Dactinomycin—skin cancer	0.000422	0.00184	CcSEcCtD
Nisoldipine—Tremor—Temozolomide—skin cancer	0.00042	0.00183	CcSEcCtD
Nisoldipine—Alopecia—Fluorouracil—skin cancer	0.000419	0.00183	CcSEcCtD
Nisoldipine—Diarrhoea—Imiquimod—skin cancer	0.000417	0.00182	CcSEcCtD
Nisoldipine—Discomfort—Dactinomycin—skin cancer	0.000417	0.00182	CcSEcCtD
Nisoldipine—Ill-defined disorder—Temozolomide—skin cancer	0.000416	0.00182	CcSEcCtD
Nisoldipine—Anaemia—Temozolomide—skin cancer	0.000414	0.00181	CcSEcCtD
Nisoldipine—Anorexia—Bleomycin—skin cancer	0.000413	0.0018	CcSEcCtD
Nisoldipine—Angioedema—Temozolomide—skin cancer	0.000409	0.00179	CcSEcCtD
Nisoldipine—Hypotension—Bleomycin—skin cancer	0.000405	0.00177	CcSEcCtD
Nisoldipine—Oedema—Dactinomycin—skin cancer	0.000404	0.00177	CcSEcCtD
Nisoldipine—Malaise—Temozolomide—skin cancer	0.000404	0.00176	CcSEcCtD
Nisoldipine—Dizziness—Imiquimod—skin cancer	0.000403	0.00176	CcSEcCtD
Nisoldipine—Vertigo—Temozolomide—skin cancer	0.000402	0.00176	CcSEcCtD
Nisoldipine—Leukopenia—Temozolomide—skin cancer	0.000401	0.00175	CcSEcCtD
Nisoldipine—Palpitations—Temozolomide—skin cancer	0.000396	0.00173	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000395	0.00172	CcSEcCtD
Nisoldipine—CYP3A4—female reproductive system—skin cancer	0.000391	0.00825	CbGeAlD
Nisoldipine—Cough—Temozolomide—skin cancer	0.000391	0.00171	CcSEcCtD
Nisoldipine—Paraesthesia—Bleomycin—skin cancer	0.000389	0.0017	CcSEcCtD
Nisoldipine—Weight increased—Docetaxel—skin cancer	0.000389	0.0017	CcSEcCtD
Nisoldipine—Weight decreased—Docetaxel—skin cancer	0.000387	0.00169	CcSEcCtD
Nisoldipine—Dyspnoea—Bleomycin—skin cancer	0.000386	0.00169	CcSEcCtD
Nisoldipine—Anorexia—Dactinomycin—skin cancer	0.000385	0.00168	CcSEcCtD
Nisoldipine—Rash—Imiquimod—skin cancer	0.000385	0.00168	CcSEcCtD
Nisoldipine—Dermatitis—Imiquimod—skin cancer	0.000384	0.00168	CcSEcCtD
Nisoldipine—Headache—Imiquimod—skin cancer	0.000382	0.00167	CcSEcCtD
Nisoldipine—Anaemia—Fluorouracil—skin cancer	0.000381	0.00167	CcSEcCtD
Nisoldipine—Arthralgia—Temozolomide—skin cancer	0.000381	0.00167	CcSEcCtD
Nisoldipine—Myalgia—Temozolomide—skin cancer	0.000381	0.00167	CcSEcCtD
Nisoldipine—Anxiety—Temozolomide—skin cancer	0.00038	0.00166	CcSEcCtD
Nisoldipine—Discomfort—Temozolomide—skin cancer	0.000377	0.00165	CcSEcCtD
Nisoldipine—Decreased appetite—Bleomycin—skin cancer	0.000377	0.00165	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Docetaxel—skin cancer	0.000376	0.00164	CcSEcCtD
Nisoldipine—Myocardial infarction—Docetaxel—skin cancer	0.000374	0.00163	CcSEcCtD
Nisoldipine—Dry mouth—Temozolomide—skin cancer	0.000373	0.00163	CcSEcCtD
Nisoldipine—ABCB1—epithelium—skin cancer	0.000373	0.00786	CbGeAlD
Nisoldipine—Stomatitis—Docetaxel—skin cancer	0.000372	0.00162	CcSEcCtD
Nisoldipine—Conjunctivitis—Docetaxel—skin cancer	0.000371	0.00162	CcSEcCtD
Nisoldipine—Leukopenia—Fluorouracil—skin cancer	0.000369	0.00161	CcSEcCtD
Nisoldipine—Confusional state—Temozolomide—skin cancer	0.000369	0.00161	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000368	0.00161	CcSEcCtD
Nisoldipine—Oedema—Temozolomide—skin cancer	0.000366	0.0016	CcSEcCtD
Nisoldipine—Nausea—Imiquimod—skin cancer	0.000362	0.00158	CcSEcCtD
Nisoldipine—Epistaxis—Docetaxel—skin cancer	0.00036	0.00157	CcSEcCtD
Nisoldipine—Feeling abnormal—Bleomycin—skin cancer	0.000357	0.00156	CcSEcCtD
Nisoldipine—Hyperhidrosis—Temozolomide—skin cancer	0.000353	0.00154	CcSEcCtD
Nisoldipine—Myalgia—Fluorouracil—skin cancer	0.000351	0.00154	CcSEcCtD
Nisoldipine—Chest pain—Fluorouracil—skin cancer	0.000351	0.00154	CcSEcCtD
Nisoldipine—Decreased appetite—Dactinomycin—skin cancer	0.000351	0.00153	CcSEcCtD
Nisoldipine—Anorexia—Temozolomide—skin cancer	0.000348	0.00152	CcSEcCtD
Nisoldipine—Discomfort—Fluorouracil—skin cancer	0.000347	0.00152	CcSEcCtD
Nisoldipine—Urticaria—Bleomycin—skin cancer	0.000344	0.0015	CcSEcCtD
Nisoldipine—Rhinitis—Docetaxel—skin cancer	0.000343	0.0015	CcSEcCtD
Nisoldipine—Body temperature increased—Bleomycin—skin cancer	0.000343	0.0015	CcSEcCtD
Nisoldipine—Hypoaesthesia—Docetaxel—skin cancer	0.00034	0.00149	CcSEcCtD
Nisoldipine—Confusional state—Fluorouracil—skin cancer	0.00034	0.00148	CcSEcCtD
Nisoldipine—Pharyngitis—Docetaxel—skin cancer	0.00034	0.00148	CcSEcCtD
Nisoldipine—Oedema peripheral—Docetaxel—skin cancer	0.000337	0.00147	CcSEcCtD
Nisoldipine—Oedema—Fluorouracil—skin cancer	0.000337	0.00147	CcSEcCtD
Nisoldipine—Feeling abnormal—Dactinomycin—skin cancer	0.000333	0.00146	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000333	0.00146	CcSEcCtD
Nisoldipine—Insomnia—Temozolomide—skin cancer	0.000331	0.00144	CcSEcCtD
Nisoldipine—Visual impairment—Docetaxel—skin cancer	0.00033	0.00144	CcSEcCtD
Nisoldipine—Tachycardia—Fluorouracil—skin cancer	0.000329	0.00144	CcSEcCtD
Nisoldipine—Paraesthesia—Temozolomide—skin cancer	0.000328	0.00143	CcSEcCtD
Nisoldipine—Dyspnoea—Temozolomide—skin cancer	0.000326	0.00142	CcSEcCtD
Nisoldipine—Somnolence—Temozolomide—skin cancer	0.000325	0.00142	CcSEcCtD
Nisoldipine—ABCB1—mammalian vulva—skin cancer	0.000324	0.00682	CbGeAlD
Nisoldipine—Dyspepsia—Temozolomide—skin cancer	0.000322	0.00141	CcSEcCtD
Nisoldipine—Anorexia—Fluorouracil—skin cancer	0.000321	0.0014	CcSEcCtD
Nisoldipine—Body temperature increased—Dactinomycin—skin cancer	0.00032	0.0014	CcSEcCtD
Nisoldipine—Hypersensitivity—Bleomycin—skin cancer	0.000319	0.00139	CcSEcCtD
Nisoldipine—Decreased appetite—Temozolomide—skin cancer	0.000318	0.00139	CcSEcCtD
Nisoldipine—Hypotension—Fluorouracil—skin cancer	0.000315	0.00138	CcSEcCtD
Nisoldipine—Chills—Docetaxel—skin cancer	0.000307	0.00134	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000307	0.00134	CcSEcCtD
Nisoldipine—Pruritus—Bleomycin—skin cancer	0.000307	0.00134	CcSEcCtD
Nisoldipine—Insomnia—Fluorouracil—skin cancer	0.000305	0.00133	CcSEcCtD
Nisoldipine—Paraesthesia—Fluorouracil—skin cancer	0.000302	0.00132	CcSEcCtD
Nisoldipine—Alopecia—Docetaxel—skin cancer	0.000302	0.00132	CcSEcCtD
Nisoldipine—Feeling abnormal—Temozolomide—skin cancer	0.000301	0.00132	CcSEcCtD
Nisoldipine—Dyspnoea—Fluorouracil—skin cancer	0.0003	0.00131	CcSEcCtD
Nisoldipine—Somnolence—Fluorouracil—skin cancer	0.000299	0.00131	CcSEcCtD
Nisoldipine—Hypersensitivity—Dactinomycin—skin cancer	0.000298	0.0013	CcSEcCtD
Nisoldipine—Dyspepsia—Fluorouracil—skin cancer	0.000297	0.0013	CcSEcCtD
Nisoldipine—Decreased appetite—Fluorouracil—skin cancer	0.000293	0.00128	CcSEcCtD
Nisoldipine—Dysgeusia—Docetaxel—skin cancer	0.000292	0.00127	CcSEcCtD
Nisoldipine—Urticaria—Temozolomide—skin cancer	0.00029	0.00127	CcSEcCtD
Nisoldipine—Body temperature increased—Temozolomide—skin cancer	0.000289	0.00126	CcSEcCtD
Nisoldipine—ABCB1—lymphoid tissue—skin cancer	0.000287	0.00605	CbGeAlD
Nisoldipine—Muscle spasms—Docetaxel—skin cancer	0.000286	0.00125	CcSEcCtD
Nisoldipine—Feeling abnormal—Fluorouracil—skin cancer	0.000278	0.00121	CcSEcCtD
Nisoldipine—ABCB1—female reproductive system—skin cancer	0.000277	0.00584	CbGeAlD
Nisoldipine—Diarrhoea—Dactinomycin—skin cancer	0.000277	0.00121	CcSEcCtD
Nisoldipine—Anaemia—Docetaxel—skin cancer	0.000275	0.0012	CcSEcCtD
Nisoldipine—Rash—Bleomycin—skin cancer	0.000273	0.00119	CcSEcCtD
Nisoldipine—Dermatitis—Bleomycin—skin cancer	0.000273	0.00119	CcSEcCtD
Nisoldipine—Hypersensitivity—Temozolomide—skin cancer	0.000269	0.00118	CcSEcCtD
Nisoldipine—Urticaria—Fluorouracil—skin cancer	0.000268	0.00117	CcSEcCtD
Nisoldipine—Syncope—Docetaxel—skin cancer	0.000267	0.00117	CcSEcCtD
Nisoldipine—Leukopenia—Docetaxel—skin cancer	0.000267	0.00116	CcSEcCtD
Nisoldipine—Body temperature increased—Fluorouracil—skin cancer	0.000266	0.00116	CcSEcCtD
Nisoldipine—Palpitations—Docetaxel—skin cancer	0.000263	0.00115	CcSEcCtD
Nisoldipine—Loss of consciousness—Docetaxel—skin cancer	0.000262	0.00114	CcSEcCtD
Nisoldipine—Cough—Docetaxel—skin cancer	0.00026	0.00114	CcSEcCtD
Nisoldipine—Pruritus—Temozolomide—skin cancer	0.000259	0.00113	CcSEcCtD
Nisoldipine—Nausea—Bleomycin—skin cancer	0.000257	0.00112	CcSEcCtD
Nisoldipine—Rash—Dactinomycin—skin cancer	0.000255	0.00111	CcSEcCtD
Nisoldipine—Myalgia—Docetaxel—skin cancer	0.000254	0.00111	CcSEcCtD
Nisoldipine—Chest pain—Docetaxel—skin cancer	0.000254	0.00111	CcSEcCtD
Nisoldipine—Arthralgia—Docetaxel—skin cancer	0.000254	0.00111	CcSEcCtD
Nisoldipine—Diarrhoea—Temozolomide—skin cancer	0.00025	0.00109	CcSEcCtD
Nisoldipine—Hypersensitivity—Fluorouracil—skin cancer	0.000248	0.00108	CcSEcCtD
Nisoldipine—Dry mouth—Docetaxel—skin cancer	0.000248	0.00108	CcSEcCtD
Nisoldipine—Confusional state—Docetaxel—skin cancer	0.000245	0.00107	CcSEcCtD
Nisoldipine—Oedema—Docetaxel—skin cancer	0.000243	0.00106	CcSEcCtD
Nisoldipine—Dizziness—Temozolomide—skin cancer	0.000242	0.00106	CcSEcCtD
Nisoldipine—Nausea—Dactinomycin—skin cancer	0.00024	0.00105	CcSEcCtD
Nisoldipine—Shock—Docetaxel—skin cancer	0.000239	0.00104	CcSEcCtD
Nisoldipine—Pruritus—Fluorouracil—skin cancer	0.000238	0.00104	CcSEcCtD
Nisoldipine—Tachycardia—Docetaxel—skin cancer	0.000237	0.00104	CcSEcCtD
Nisoldipine—Anorexia—Docetaxel—skin cancer	0.000232	0.00101	CcSEcCtD
Nisoldipine—ABCB1—head—skin cancer	0.000231	0.00488	CbGeAlD
Nisoldipine—Rash—Temozolomide—skin cancer	0.000231	0.00101	CcSEcCtD
Nisoldipine—Diarrhoea—Fluorouracil—skin cancer	0.00023	0.00101	CcSEcCtD
Nisoldipine—Dermatitis—Temozolomide—skin cancer	0.00023	0.00101	CcSEcCtD
Nisoldipine—Headache—Temozolomide—skin cancer	0.000229	0.001	CcSEcCtD
Nisoldipine—Hypotension—Docetaxel—skin cancer	0.000227	0.000992	CcSEcCtD
Nisoldipine—Dizziness—Fluorouracil—skin cancer	0.000223	0.000973	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000222	0.000968	CcSEcCtD
Nisoldipine—Insomnia—Docetaxel—skin cancer	0.00022	0.000961	CcSEcCtD
Nisoldipine—Paraesthesia—Docetaxel—skin cancer	0.000218	0.000954	CcSEcCtD
Nisoldipine—Nausea—Temozolomide—skin cancer	0.000217	0.000949	CcSEcCtD
Nisoldipine—Dyspnoea—Docetaxel—skin cancer	0.000217	0.000947	CcSEcCtD
Nisoldipine—Somnolence—Docetaxel—skin cancer	0.000216	0.000944	CcSEcCtD
Nisoldipine—Dyspepsia—Docetaxel—skin cancer	0.000214	0.000935	CcSEcCtD
Nisoldipine—Rash—Fluorouracil—skin cancer	0.000212	0.000928	CcSEcCtD
Nisoldipine—Dermatitis—Fluorouracil—skin cancer	0.000212	0.000927	CcSEcCtD
Nisoldipine—Decreased appetite—Docetaxel—skin cancer	0.000211	0.000923	CcSEcCtD
Nisoldipine—Headache—Fluorouracil—skin cancer	0.000211	0.000922	CcSEcCtD
Nisoldipine—Feeling abnormal—Docetaxel—skin cancer	0.0002	0.000875	CcSEcCtD
Nisoldipine—Nausea—Fluorouracil—skin cancer	0.0002	0.000874	CcSEcCtD
Nisoldipine—Body temperature increased—Docetaxel—skin cancer	0.000192	0.00084	CcSEcCtD
Nisoldipine—Hypersensitivity—Docetaxel—skin cancer	0.000179	0.000783	CcSEcCtD
Nisoldipine—Pruritus—Docetaxel—skin cancer	0.000172	0.000751	CcSEcCtD
Nisoldipine—Diarrhoea—Docetaxel—skin cancer	0.000166	0.000727	CcSEcCtD
Nisoldipine—ABCB1—lymph node—skin cancer	0.000162	0.00342	CbGeAlD
Nisoldipine—Dizziness—Docetaxel—skin cancer	0.000161	0.000702	CcSEcCtD
Nisoldipine—Rash—Docetaxel—skin cancer	0.000153	0.00067	CcSEcCtD
Nisoldipine—Dermatitis—Docetaxel—skin cancer	0.000153	0.000669	CcSEcCtD
Nisoldipine—Headache—Docetaxel—skin cancer	0.000152	0.000665	CcSEcCtD
Nisoldipine—Nausea—Docetaxel—skin cancer	0.000144	0.000631	CcSEcCtD
